Tremendous scientific advancements have been made in the last decade to prevent the transmission of HIV and improve the lives of people living with HIV. Today the world can see the possibility of an AIDS-free generation, but many challenges remain. In 2015 there were still 2.1 million new HIV infections and 36.7 million people living with the virus worldwide.
PSI is committed to taking an active role in creating an AIDS-free generation by implementing evidence-based, cost-effective interventions in collaboration with country governments and other partners.
We implement our HIV programs through a combination of preventative actions: providing evidence-based biomedical, behavioral and structural interventions to reduce the burden of HIV. Our network members market high-quality, affordable products, such as male and female condoms, lubricants and sterile injecting equipment. We also provide high-quality health services such a HIV testing and counseling, voluntary medical male circumcision, ARV-based prevention and HIV treatment. Using our social marketing and social franchising expertise, we strengthen the public and private sector’s ability to provide these important HIV products and services to priority populations who are at risk of HIV infection. Since inception, our HIV programs have prevented millions of new infections and improved the lives of countless people living with, and affected by, HIV.
In 2013, our HIV and STI programs averted an estimated 254,792 HIV infections and over 10.5 million DALYs.
To address the burden of HIV in the countries where we work, PSI implements biomedical, behavioral and structural interventions using a combination of preventative actions. Read more about our interventions.
- Behavior change communication: We promote behavioral change, reduce risky behaviors and address negative social norms through innovative communication activities.
- Combination prevention: Combination prevention is the backbone of our efforts to deliver HIV prevention solutions at scale across the globe.
- Condoms and lubricant: We use private sector marketing strategies to increase demand for and access to attractively packaged, affordable, and high-quality male latex condoms, female condoms, and water based lubricant.
- Gender-based violence: Our network leverages HIV programs in a number of countries to address gender-based violence.
- HIV counseling and testing: We provide HIV counseling and testing services through a network of directly and indirectly managed health service delivery sites.
- Needle and syringe distribution: Our comprehensive harm reduction programs work to reduce the risk faced by people who inject drugs.
- Reproductive health/HIV integration: We offer contraceptive methods and services when and where other healthcare services are offered, to increase client access to the information and care needed to manage sexual and reproductive health.
- Stigma and discrimination: We sensitize healthcare providers to care for priority populations with respect and to offer them services that best fit their needs.
- Treatment care and support: Since HIV testing and counseling acts as the entry point to HIV care and treatment, where we provide HIV testing and counseling services we work closely with treatment programs in the public sector.
- Voluntary medical male circumcision (VMMC): We have launched and scaled up VMMC service delivery, communications and advocacy initiatives in nine African countries.
Priority populations: Although we work with many priority populations, four populations are particularly central to our work: people who inject drugs (PWID), men who have sex with men (MSM) and female sex workers (FSW).
- Ignite and PSI Mozambique’s TEM+ Escolas: Bringing Contraceptive Counseling and Product Delivery to Schools
In Mozambique, PSI’s network of Tem+ clinics are delivering contraceptive counseling and products directly to schools, challenging negative attitudes towards youth access to SRH services while simultaneously creating a positive enabling environment at the service delivery level. - Kenya HIV Self-Testing Landscape
Formative market and consumer research to understand the HIVST landscape in Kenya, with a focus on regulatory and cost constraints. Recommendations to develop the private sector market (pharmacy distribution) of HIVST to help close the testing gap among men and youth. Framed as an update to donors who could invest in market shaping interventions. - How PSI Generates Value for Money through Social Investments
This 2-page brief describes the principles of cost-effectiveness, world-class financial management and risk reduction procedures that PSI uses to deliver cost-efficient impact for our partners. - USAID Central Asia Flagship Project 2017 Results
PSI CA has recently completed year 2 out a 5-year long USAID Central Asia HIV Flagship Activity providing services to people living with HIV (PLHIV), people who inject drugs (PWID) and men who sex with men (MSM), linking HIV positive clients to care and treatment, as well as testing services to their partners and those at highest risk of HIV. This infographic serves to provide information on the results from year 2 of the Project. - Expanding Effective Contraceptive Options in Zambia and Malawi: Understanding the Consumer
Expanding Effective Contraceptive Options (EECO) is a USAID-funded project led by WCG with PSI and other partners to support the introduction of new contraceptive and dual protection methods. This case study presents EECO’s analysis of consumer insights and market data to develop a marketing strategy for the Woman’s Condom in Malawi and Zambia. - Costs of Facility-Based HIV Testing in Malawi, Zambia and Zimbabwe
We sought to explore the costs of providing these services across three southern African countries with high HIV burden. Primary costing studies were undertaken in 54 health facilities providing HIV testing services (HTS) in Malawi, Zambia and Zimbabwe. The mean cost per individuals tested was US$5.17 in Malawi, US$4.24 in Zambia and US$8.79 in Zimbabwe. The mean cost per HIV-positive individual identified was US$79.58, US$73.63, and US$178.92 in Malawi, Zambia and Zimbabwe respectively. Both cost estimates were sensitive to scale of testing, facility staffing levels and the costs of HIV test kits. - Nigeria FPwatch 2015 Reference Document
This outlet report contains the findings from the 2015 FPwatch outlet survey conducted in Nigeria. - Nigeria FPwatch 2015 Outlet Survey Research Brief
This brief highlights important findings from the FPwatch 2015 Nigeria outlet survey. - Nigeria FPwatch 2015 Overview
This document summarizes the implementation and key findings of the FPwatch 2015 outlet survey in Nigeria. - Nigeria FPwatch 2015 Outlet Survey Dissemination Report
Data from the 2015 FPwatch outlet survey were shared at the dissemination event held in December 2016 in Abuja, Nigeria.